XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues    
Total revenues, net $ 33,126,335 $ 29,042,837
Cost of revenues    
Total cost of revenues 4,214,969 5,248,175
Gross profit 28,911,366 23,794,662
Expenses    
Selling and marketing expenses 16,717,645 21,909,825
General and administrative expenses 10,602,763 12,212,743
Other operating expenses 1,704,765 1,417,469
Customer service expenses 1,555,404 933,307
Development costs 1,183,599 428,333
Total expenses 31,764,176 36,901,677
Operating loss (2,852,810) (13,107,015)
Interest expense, net (264,465) (167,934)
Loss on debt extinguishment (325,198)
Net loss (3,442,473) (13,274,949)
Net income attributable to non-controlling interest 565,983 24,726
Net loss attributable to LifeMD, Inc. (4,008,456) (13,299,675)
Preferred stock dividends (776,563) (776,563)
Net loss attributable to LifeMD, Inc. common stockholders $ (4,785,019) $ (14,076,238)
Basic loss per share attributable to LifeMD, Inc. common stockholders $ (0.15) $ (0.46)
Diluted loss per share attributable to LifeMD, Inc. common stockholders $ (0.15) $ (0.46)
Weighted average number of common shares outstanding:    
Basic 31,680,776 30,853,118
Diluted 31,680,776 30,853,118
Telehealth Revenue [Member]    
Revenues    
Total revenues, net $ 20,202,803 $ 22,598,061
Cost of revenues    
Total cost of revenues 3,920,182 5,086,068
WorkSimpli Revenue [Member]    
Revenues    
Total revenues, net 12,923,532 6,444,776
Cost of revenues    
Total cost of revenues $ 294,787 $ 162,107